TER
0,60% p.a.
Distributiebeleid
Accumulerend
Replicatie
Volledige replicatie
Fondsgrootte
7 m
Bedrijven
30
Overzicht
Verhandel deze ETF bij je broker
Beschrijving
The First Trust NYSE Arca Biotechnology UCITS ETF Acc seeks to track the NYSE Arca Biotechnology index. The NYSE Arca Biotechnology index tracks companies operating in the biotechnology industry which are listed on NYSE or Nasdaq.
Documenten
Grafiek
Basis
Data
| Index | NYSE Arca Biotechnology |
| Investeringsfocus | Aandelen, Verenigde Staten, Gezondheidszorg |
| Fondsgrootte | EUR 7 m |
| Totale kostenratio (TER) | 0,60% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | No |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 18,25% |
| Oprichtingsdatum/Noteringsdatum | 27 mei 2020 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | First Trust |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Beleggingsadviseur | First Trust Advisors L.P. |
| Bewaarbank | The Bank of New York Mellon SA/NV (Dublin Branch) |
| Revisiebedrijf | PwC |
| Einde belastingjaar | 31 december |
| Vertegenwoordiger van Zwitserland | Oligo Swiss Fund Services SA |
| Zwitserse uitbetalende instantie | Banque Cantonale de Genève |
| Duitsland | 30% belastingvermindering |
| Zwitserland | Geen ESTV-rapportage |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de First Trust NYSE Arca Biotechnology UCITS ETF Acc
Vergelijkbare ETF via ETF zoeken
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de First Trust NYSE Arca Biotechnology UCITS ETF Acc
Top 10 holdings
Weging van top 10-holdings
van 30
40,11%
| BeiGene Ltd. | 4,58% |
| Corcept Therapeutics | 4,56% |
| EXACT Sciences Corp. | 4,56% |
| BioNTech SE | 4,33% |
| Gilead Sciences, Inc. | 3,72% |
| Catalyst Pharmaceuticals, Inc. | 3,72% |
| Waters | 3,69% |
| Alkermes | 3,68% |
| Repligen Corp | 3,66% |
| argenx | 3,61% |
Landen
| Verenigde Staten | 80,92% |
| Duitsland | 4,33% |
| Ierland | 3,68% |
| Anders | 11,07% |
Sectoren
| Gezondheidszorg | 88,93% |
| Anders | 11,07% |
Vanaf 30/09/2024
Prestaties
Rendementsoverzicht
| YTD | +8,14% |
| 1 maand | -2,98% |
| 3 maanden | +0,37% |
| 6 maanden | +9,33% |
| 1 jaar | +20,50% |
| 3 jaar | +9,20% |
| 5 jaar | - |
| Since inception | +3,85% |
| 2023 | -1,30% |
| 2022 | +1,20% |
| 2021 | +4,30% |
| 2020 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 18,25% |
| Volatiliteit 3 jaar | 22,36% |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 1,12 |
| Rendement/Risico 3 jaar | 0,13 |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -9,72% |
| Maximaal waardedaling 3 jaar | -19,49% |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -25,05% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | FBT | FBT IM FBTINAV | FBT.MI | |
| London Stock Exchange | GBX | FBT | FBT LN FBTINAV | ||
| London Stock Exchange | GBP | - | FBT LN | ||
| London Stock Exchange | USD | FBTU | FBTU LN FBTINAV |
Meer informatie
Andere ETF met vergelijkbare beleggingsfocus
| Naam fonds | Fondsgrootte in €m (AuM) | TER p.j. | Distributie | Replicatiemethode |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 440 | 0,35% p.a. | Accumulerend | Sampling |
| Invesco Nasdaq Biotech UCITS ETF | 295 | 0,40% p.a. | Accumulerend | Swap-gebaseerd |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 32 | 0,35% p.a. | Distribueren | Sampling |
Nieuwste artikelen
Veelgestelde vragen
What is the name of FBT?
The name of FBT is First Trust NYSE Arca Biotechnology UCITS ETF Acc.
What is the ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The primary ticker of First Trust NYSE Arca Biotechnology UCITS ETF Acc is FBT.
What is the ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The ISIN of First Trust NYSE Arca Biotechnology UCITS ETF Acc is IE00BL0L0H60.
What are the costs of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The total expense ratio (TER) of First Trust NYSE Arca Biotechnology UCITS ETF Acc amounts to 0,60% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is First Trust NYSE Arca Biotechnology UCITS ETF Acc paying dividends?
First Trust NYSE Arca Biotechnology UCITS ETF Acc is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc?
The fund size of First Trust NYSE Arca Biotechnology UCITS ETF Acc is 7m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).